Literature DB >> 30093034

Production and characterization of supercritical CO2 dried chitosan nanoparticles as novel carrier device.

Francisco J Caro-León1, Waldo Argüelles-Monal2, Elizabeth Carvajal-Millán3, Yolanda L López-Franco4, Francisco M Goycoolea-Valencia5, Julio San Román Del Barrio6, Jaime Lizardi-Mendoza7.   

Abstract

The materials produced by the supercritical CO2 drying have outstanding properties that allow the incorporation of molecules in their porous structure. In this context, dried chitosan nanoparticles including β-lactoglobulin were obtained. First, the nanoparticles in water suspension were produced by ionotropic gelation incorporating the protein with high loading efficiency. Later, solvent exchange and CO2 supercritical drying procedures were performed. The physicochemical characteristics and structural properties were determined, demonstrating a stable porous structure in the dried materials and corroborating the presence of the protein after the drying. The CO2 supercritical dried chitosan nanoparticles can be effectively resuspended in acidic aqueous medium remaining in the nanoscale with minimum effect on the loading parameters. The release of the β-lactoglobulin was highly influenced by the pH, reaching around 40% under acidic conditions in ten hours. The obtained results demonstrate the possibility to apply these chitosan materials as a controlled release material.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CO(2) supercritical drying; Chitosan; Ionotropic gelation; Nanoparticles; β-Lactoglobulin

Year:  2018        PMID: 30093034     DOI: 10.1016/j.carbpol.2018.06.102

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  1 in total

1.  Cytotoxicity Enhancement in MCF-7 Breast Cancer Cells with Depolymerized Chitosan Delivery of α-Mangostin.

Authors:  Yedi Herdiana; Nasrul Wathoni; Shaharum Shamsuddin; Muchtaridi Muchtaridi
Journal:  Polymers (Basel)       Date:  2022-08-01       Impact factor: 4.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.